Foghorn Therapeutics Inc. Increase (Decrease) in Contract with Customer, Asset
Foghorn Therapeutics Inc. (FHTX) reported Increase (Decrease) in Contract with Customer, Asset of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-07.
Discontinued › Cash Flow
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2024-03-07
- Foghorn Therapeutics Inc. increase (decrease) in contract with customer, asset for the quarter ending 2023-12-31 was $0.00.
- Foghorn Therapeutics Inc. increase (decrease) in contract with customer, asset for the quarter ending 2023-09-30 was $0.00.
- Foghorn Therapeutics Inc. increase (decrease) in contract with customer, asset for the quarter ending 2023-06-30 was $0.00.
- Foghorn Therapeutics Inc. increase (decrease) in contract with customer, asset for the quarter ending 2023-03-31 was $0.00.
- Foghorn Therapeutics Inc. increase (decrease) in contract with customer, asset for fiscal 2023 was $0.00.
- Foghorn Therapeutics Inc. increase (decrease) in contract with customer, asset for fiscal 2022 was -$300.00M, a 200.00% decline from fiscal 2021.
- Foghorn Therapeutics Inc. increase (decrease) in contract with customer, asset for fiscal 2021 was $300.00M.
- Foghorn Therapeutics Inc. increase (decrease) in contract with customer, asset for fiscal 2020 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 9 month | Increase (Decrease) in Contract with Customer, Asset 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $0.00 derived: sum of 2 quarters · filed 2024-03-07 | $0.00 derived: sum of 3 quarters · filed 2024-03-07 | $0.00 10-K · filed 2024-03-07 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 4 quarters · filed 2024-03-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | $0.00 derived: sum of 3 quarters · filed 2024-03-07 | $0.00 derived: sum of 4 quarters · filed 2024-03-07 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-08 | $0.00 derived: sum of 2 quarters · filed 2024-03-07 | $0.00 derived: sum of 3 quarters · filed 2024-03-07 | $0.00 derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $0.00 derived: sum of 2 quarters · filed 2024-03-07 | $0.00 derived: sum of 3 quarters · filed 2024-03-07 | -$300.00M 10-K · filed 2024-03-07 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | -$300.00M 10-Q · filed 2023-11-02 | $0.00 derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$300.00M 10-Q · filed 2023-08-04 | $0.00 derived: sum of 3 quarters · filed 2023-08-04 | $0.00 derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | -$300.00M 10-Q · filed 2023-05-08 | $0.00 derived: sum of 2 quarters · filed 2023-05-08 | $0.00 derived: sum of 3 quarters · filed 2023-05-08 | $0.00 derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $300.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $300.00M derived: sum of 2 quarters · filed 2023-03-09 | $300.00M derived: sum of 3 quarters · filed 2023-03-09 | $300.00M 10-K · filed 2023-03-09 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $0.00 10-K/A · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |